Merck/Sanofi Six-in-One Vaccine for Kids Prepared by CDC, FDA For Mass Distribution, Turning Blind Eye to Safety Signals • Children’s Health Defense

Share it with your friends Like

Thanks! Share it with your friends!

Close

Since the mid-1980s, the number of childhood shots on the Centers for Disease Control and Prevention (CDC) vaccine schedule has more than quadrupled. When parents express reluctance about turning their little ones into perpetual pin cushions, drug makers and doctors have a ready answer — combination vaccines that “simplify” the schedule by decreasing the number of injections administered.

 

This month marks the U.S. launch of the Merck/Sanofi joint-venture vaccine, Vaxelis, a six-in-one (hexavalent) combination vaccine that contains diphtheria, tetanus and acellular pertussis (DTaP) components as well as components said to protect against polio, Haemophilus influenzae type b (Hib) and hepatitis B.

 

Read More: CDC, FDA Prepare Mass Distribution of a Merck/Sanofi Six-in-One Vaccine for Kids, Turning Blind Eye to Safety Signals • Children’s Health Defense

  • Rating:
  • Views:176 views
  • Categories: Health